Australia Allergy Diagnostics Market (2026-2031)
The Australia Allergy Diagnostics Market was valued at $93.7 Million in 2026 and projected to reach to $155.3 Million by 2031, representing a compound annual growth rate of 10.6%. Australia's allergy diagnostics market is positioned for sustained expansion through 2031, driven by rising allergic disease prevalence, improved diagnostic awareness, and healthcare system modernization.
Australia Allergy Diagnostics Market Trends and Insights
- This represents a compound annual growth rate (CAGR) of 10.6%, outpacing global market expansion.
- Australia's healthcare infrastructure and rising prevalence of allergic conditions are driving demand for advanced diagnostic solutions across the country. The Australian market benefits from increasing awareness of allergy testing, improved access to diagnostic technologies, and growing investment in healthcare innovation.
- Australia's aging population and environmental factors contribute to higher allergy incidence rates, spurring adoption of both traditional and molecular diagnostic methods.
- Between 2026 and 2031, Australia is expected to see significant market consolidation and technological advancement in allergy diagnostics. Australia's position within the Asia Pacific region reflects strong healthcare spending and regulatory support for diagnostic innovation.
- The market's growth trajectory indicates sustained demand for immunoassay, skin prick testing, and component-resolved diagnostics throughout the forecast period..
Key Market Statistics
- CAGR (2026-2031) 10.6% CAGR
- Market Size, 2026 ~USD 93.7 Million
- Forecast, 2031 ~USD 155.3 Million
- Country Australia
Australia Allergy Diagnostics Market Overview
Market Growth Trajectory :
Australia's allergy diagnostics market is expanding at 10.6% CAGR, growing from USD 93.7 million in 2026 to USD 155.3 million by 2031, significantly outpacing the global growth rate of 9.6%.
Rising Allergy Prevalence :
Increasing prevalence of allergic conditions across Australia's population is driving demand for advanced diagnostic solutions, supported by heightened awareness and improved healthcare access.
Healthcare Infrastructure Advantage :
Australia's robust healthcare system and high adoption of diagnostic technologies create a favorable environment for allergy diagnostics innovation and market penetration.
Regional Market Expansion :
Strong growth momentum in Australia reflects increasing investment in diagnostic capabilities, expanding clinical laboratory networks, and growing patient demand for accurate allergy testing.
Australia Allergy Diagnostics Market Dynamics
- The 10.6% CAGR reflects strong demand for both in-vitro and in-vivo diagnostic solutions across urban and regional centers.
- Key growth drivers include increasing healthcare spending, adoption of advanced testing technologies, and expanding specialist networks.
- The market will benefit from growing patient education initiatives and integration of digital health solutions in diagnostic pathways, supporting market value growth to USD 155.3 million by 2031..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- Australia's allergy diagnostics market will grow from $93.7M (2026) to $155.3M (2031) at a 10.6% CAGR.
- Australia's market growth rate exceeds the global average, driven by rising allergy prevalence and healthcare investment.
- Australia's diagnostic landscape is shifting toward advanced molecular and component-resolved testing methods.
- Australia's healthcare infrastructure and regulatory environment support sustained market expansion through 2031.
Allergy Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IN VITRO TESTS (Test Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 9.6% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 6.81 (2026) |
| Revenue Forecast (Billions) | ~USD 10.77 (2031) |
| Segments Covered | Product & Service, Type, Test Type, Allergen, End User |
Australia Allergy Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Consumables
- Instruments
- Services
By Type
- Immunoassay Analyzers
- Luminometers
- Other In Vivo Tests
- Other Instruments
- Patch Tests
- Skin Prick Tests
By Test Type
- In Vitro Tests
- In Vivo Tests
By Allergen
- Drug Allergens
- Food Allergens
- Inhaled Allergens
- Other Allergens
By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Hospital-Based Laboratories
- Other End Users
Target Audience
- Diagnostic Equipment Manufacturers : Need Australia-specific market data to assess market opportunity, plan product launches, and develop localized marketing strategies for allergy diagnostic devices and platforms.
- In Vitro Diagnostics (IVD) Companies : Require detailed market insights on testing methodologies, reimbursement landscape, and clinical adoption rates in Australia to optimize product portfolios and pricing strategies.
- Healthcare Providers & Laboratories : Seek market intelligence on diagnostic trends, patient demand patterns, and competitive offerings in Australia to enhance service delivery and investment in allergy testing capabilities.
- Investment & Private Equity Firms : Need comprehensive market analysis of Australia's allergy diagnostics sector to evaluate investment opportunities, assess growth potential, and identify acquisition targets in the region.
- Healthcare Consultants & Advisors : Require Australia-specific market data and forecasts to provide strategic recommendations to clients on market entry, expansion, and competitive positioning in allergy diagnostics.
Key Companies in the Australia Allergy Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| TECAN GROUP LTD. | Switzerland |
TECAN GROUP LTD.
TECAN GROUP LTD. is a Swiss life sciences company providing laboratory automation and diagnostic instruments.
Reasons to Buy this Report
- Market Size & Growth Data : Access precise market valuations for Australia (USD 93.7M in 2026, USD 155.3M in 2031) with detailed CAGR analysis to support investment decisions and business planning in the region.
- Competitive Landscape Intelligence : Understand market dynamics specific to Australia, including key players, market share distribution, and competitive positioning to identify partnership and expansion opportunities.
- Regulatory & Healthcare Insights : Gain country-specific knowledge of Australian healthcare regulations, reimbursement policies, and diagnostic standards that impact market entry and product commercialization strategies.
- Demand Drivers & Trends : Identify Australia-specific factors driving allergy diagnostics adoption, including prevalence rates, patient demographics, and emerging diagnostic technologies gaining traction in the market.
- Strategic Market Positioning : Develop targeted go-to-market strategies for Australia with data-driven insights on regional preferences, distribution channels, and customer segments to maximize market penetration.
Frequently asked questions
What is the current size of Australia's allergy diagnostics market?
Australia's allergy diagnostics market is valued at USD 93.7 million in 2026 and is projected to reach USD 155.3 million by 2031.
What is the growth rate of Australia's allergy diagnostics market?
Australia's allergy diagnostics market is growing at a compound annual growth rate (CAGR) of 10.6% from 2026 to 2031.
What factors are driving growth in Australia's allergy diagnostics market?
Key drivers include rising allergy prevalence, increased healthcare awareness, aging population demographics, environmental factors, and investment in diagnostic innovation across Australia.
Which diagnostic methods are most prevalent in Australia's market?
Australia's market includes immunoassay, skin prick testing, and component-resolved diagnostics, with growing adoption of advanced molecular testing methods.
How does Australia's market compare to global trends?
Australia's 10.6% CAGR exceeds the global average of 9.6%, reflecting strong healthcare spending and regulatory support for diagnostic innovation in the country.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global Allergy Diagnostic market. Exhaustive secondary research was done to collect information on the allergy diagnostic market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the allergy diagnostic market's segments and subsegments.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ in-house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the allergy diagnostic market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/managing directors, marketing heads/directors and sales directors, marketing/sales managers, regional/area sales managers, export/import heads/managers, and other market-related personnel from various companies and organizations operating in the allergy diagnostic market. Primary sources from the demand side included vice presidents in hospitals & clinics, C-level executives, department heads, doctors/physicians, hospital supply management teams, clinic personnel, and laboratory technicians.
Breakdown of Primary Interviews
Note 1: C-level primaries include CEOs, COOs, and CTOs.
Note 2: Others include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the allergy diagnostic market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The market was divided into four segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the market engineering process and arrive at precise statistics for all segments.
Approach to derive the market size and estimate market growth: Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of allergy diagnostic products. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
Allergy testing helps determine the substances causing a patient's allergy symptoms. Tests include skin tests, intradermal tests, challenge tests, blood tests, and patch tests. Allergists commonly conduct challenge tests, including food, inhalation, drug, and physical challenges. Blood tests are generally used when unsafe or unapplicable skin tests are required, such as when consuming certain medications or having a skin condition that may interfere with skin testing. Allergy tests, such as in vitro & in vivo tests, are performed to determine the cause, stage, prognosis, and treatment course for allergic diseases.
Key Stakeholders
- Allergy Diagnostic Reagents, Kits, and Instrument Manufacturers
- Allergy Diagnostic Vendors and Distributors
- Hospitals
- Diagnostic Laboratories
- Allergy Diagnostic Service Providers
- Academic Research Institutes
- Venture Capitalists and Investors
- Contract Research Organizations (CROs)
Report Objectives
- To describe, analyze, and forecast the allergy diagnostic market, by product & service, test type, allergen, end user, and region
- To describe and forecast the allergy diagnostic market for key regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the allergy diagnostic market
- To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s Five Forces, and prices pertaining to the market under study
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the allergy diagnostic market
- To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the allergy diagnostic market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific allergy diagnostic market into Vietnam, New Zealand, and others
- Further breakdown of the Rest of Latin America allergy diagnostic market into Colombia, Chile, Ecuador, and others
- Further breakdown of the Rest of Europe allergy diagnostic market into Belgium, Russia, the Netherlands, Switzerland, and others
Get the Full Allergy Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Allergy Diagnostics Market.
- Canada Allergy Diagnostics Market
- US Allergy Diagnostics Market
- Germany Allergy Diagnostics Market
- UK Allergy Diagnostics Market
- France Allergy Diagnostics Market
- Italy Allergy Diagnostics Market
- Spain Allergy Diagnostics Market
- China Allergy Diagnostics Market
- Japan Allergy Diagnostics Market
- India Allergy Diagnostics Market
- South Korea Allergy Diagnostics Market
- Brazil Allergy Diagnostics Market
- Mexico Allergy Diagnostics Market
- GCC Countries Allergy Diagnostics Market
- Rest Of Europe Allergy Diagnostics Market
- Rest Of Asia Pacific Allergy Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report